News | February 04, 2022
Pfizer Q3FY22 PAT at Rs 143.91 crore
The company has reported standalone financial results for the period ended December 31, 2021.
The company has reported standalone financial results for the period ended December 31, 2021.
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
Pristyn Care operates on an innovative full- stack Care Delivery model to ensure that high quality surgical care is offered to patients at an affordable cost
A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook
The audit is a PAI for two of its product applications filed from this facility
ICICI Direct’s analysis of Cipla’s Q3FY22 results
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
